All News

In a bonus episode of the Over the Counter podcast, William A. Bryson, PharmD, joined to help celebrate Diabetes Alert Day—recognized annually on the fourth Tuesday in March.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

Many patients struggle with the everyday realities of staying on the medication, which can include uncomfortable adverse effects.

With efforts to further scale naloxone access in US community pharmacies, researchers explore the implementation of a hub-and-spoke distribution model.

Lilly’s once-weekly retatrutide lowers A1C up to 2% and drives nearly 17% weight loss in type 2 diabetes, signaling a powerful triple-agonist shift.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, provides nuance and understanding to the FDA’s recent push to move, essentially, ‘every’ drug to OTC formulation.

The SUPPORT Act 2025 lets pharmacists prescribe buprenorphine for opioid use disorder, but DEA training and state rules shape access and new formulations.

Along with presenting best practices for pharmacies’ vaccination workflows, researchers explore the impact of community pharmacies offering technician-administered vaccines.

Mississippi pharmacies strengthen prenatal care with monthly check-ins, vitamins, aspirin, screenings, and community support for high-risk moms.

Across the United States, trafficking also takes the form of labor exploitation in farms, factories, and remote industrial regions.

With the OPUS-1, 2, and 3 trials underway, Vax-31 has the potential to become the first pneumococcal vaccine of its kind, demonstrating never-before-seen impacts on disease burden.

MAHA-driven HHS shifts vaccines and nutrition, fueling public health debate as pharmacists battle social media misinformation and rebuild trust.

The FDA clears the highest-dose weekly semaglutide for obesity, showing 20.7% mean weight loss with the same blood sugar-lowering effects.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

Pharmacists spot subtle abuse and sexual health red flags, avoid profiling, and respond safely with resources while protecting HIPAA privacy.

Pharmacists help women with type 1 diabetes plan pregnancy, adjust insulin and tech, and stay safe postpartum with personalized guidance.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

MiniMed Flex is a smaller, screenless, and phone-controlled insulin automation that shows how pharmacists boost AID success for patients with diabetes.

Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.

The new parameter combines waist circumference, hypertension status, and glycated hemoglobin to determine insulin resistance.

FDA approves icotrokinra as a first-line systemic treatment of plaque psoriasis with a targeted oral peptide for adults and pediatric patients.

Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

Investigators used a large cohort of patients from Taiwan between 2004 and 2015 to determine the potential link between Tylenol use and childhood neurodevelopment.

Combined with nutritional interventions, semaglutide also demonstrates greater weight loss compared with dulaglutide.

CDC researchers investigate pneumococcal disease cases and intervention strategies within a North Carolina correctional facility from June 14 to July 30, 2024.

The health care landscape for metabolic liver disease is undergoing a shift, and pharmacists are being positioned at the forefront of this therapeutic revolution.